Quest Diagnostics (DGX) Capital Expenditures (2009 - 2026)

Quest Diagnostics has disclosed Capital Expenditures across 18 years of filings, most recently posting $138.0 million for Q2 2026.

• In Q2 2026, Capital Expenditures rose 27.78% year-over-year to $138.0 million; the TTM figure through Jun 2026 stood at $554.0 million (up 22.03% YoY), while the FY2025 annual figure was $527.0 million, up 24.0% from the prior year.
• Capital Expenditures came in at $138.0 million for Q2 2026 at Quest Diagnostics, up from $114.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $158.0 million in Q4 2025 to a low of $63.0 million in Q1 2022.
• Average Capital Expenditures over 5 years is $112.0 million, with a median of $111.0 million recorded in 2025.
• The largest YoY upside for Capital Expenditures was 101.59% in 2023 against a maximum downside of 51.02% in 2023.
• Over 5 years, Capital Expenditures stood at $147.0 million in 2022, then slumped by 51.02% to $72.0 million in 2023, then surged by 70.83% to $123.0 million in 2024, then increased by 28.46% to $158.0 million in 2025, then fell by 12.66% to $138.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $138.0 million in Q2 2026, $114.0 million in Q1 2026, and $158.0 million in Q4 2025.